MITRALLEAFLET TETHERING
#602Responsive Biomechanical Implants and Devices
#603SYSTEM AND METHOD FOR TREATMENT AND PREVENTION OF PERIPROSTHETIC JOINT INFECTIONS
#604Apparatus and Methods for Small Joint and Bony Defect Replacement
#605SHOULDER PROSTHESIS COMPONENTS AND ASSEMBLIES
#606Implantable Non-Fusion Growth Modulating System
#607LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD
#608EXPANDABLE INTERVERTEBRAL IMPLANT
#609SYSTEMS AND METHODS FOR FLEXURE-BASED STANDALONE INTERBODY FUSION
#610INTERBODY FUSION DEVICES AND RELATED METHODS OF MANUFACTURE
#611EXPANDABLE INTERVERTEBRAL IMPLANT BY CONICAL SCREW ELEMENT AND SYSTEM
#612EXPANDABLE FUSION IMPLANT AND RELATED METHODS
#613JOINT IMPLANT EXTRACTION AND PLACEMENT SYSTEM AND LOCALIZATION DEVICE USED THEREWITH
#614SPINAL IMPLANT DEVICE
#615Bone Preparation Device
#616BREAST PROSTHETIC DEVICE, FASTENING SYSTEM, AND USES THEREOF
#617PROSTHETIC LIMB WITH THERMO-ELECTRIC ACTUATOR
#618ADJUSTABLE DEVICES AND RELATED SYSTEMS AND METHODS
#619PROSTHETIC PYLON EMULATOR
#620ENDOVASCULAR PROSTHESIS WITH SELECTIVELY OPENABLE INTERNAL DUCT
#621SYSTEMS AND METHODS FOR MANUFACTURING A STENT FRAME
#622VASCULAR STENT AND MANUFACTURING PROCESS THEREFOR
#623REPOSITIONABLE AND REMOVABLE STENTS
#624BALLOON CATHETER ASSEMBLY
#625POSTURE CORRECTION BRACE
#626CERVICAL IMMOBILIZATION DEVICE
#627APPARATUS AND METHODS FOR RECEIVING DISCHARGED URINE
#628URINE MANAGEMENT SYSTEMS AND METHODS
#629OSTOMY APPLIANCE COUPLING ASSEMBLY
#630Non-Invasive Female Catheter System
#631MOBILE CRYOTHERAPY DEVICE
#632TEMPERATURE THERAPY GARMENT AND METHOD
#633Adjustable Therapy Wrap
#634TREATMENT OF SPINAL MUSCULAR ATROPHY BY INDUCING HEAT SHOCK RESPONSE
#635OCULAR DRUG DELIVERY DEVICES SECURELY IMPLANTABLE INTO ANTERIOR SEGMENT OF EYE
#636PUNCTAL PLUG AND BIOADHESIVES
#637INTRAOCULAR SHUNT IMPLANTATION
#638INTRAOCULAR SYSTEMS, DEVICES, KITS, AND METHODS
#639INTELLIGENT DETECTION AND TREATMENT OF ISCHEMIC TISSUE
#640DYNAMIC SURGICAL FEEDBACK FOR EYE TISSUE
#641HANDHELD FIBER PROBE FOR LASER TREATMENT OF MEDICAL TISSUE, IN PARTICULAR FOR TREATMENT OF GLAUCOMA
#642Tissue-Augmented Corneal Inlay Surgery Technique
#643OPHTHALMIC LASER TREATMENT DEVICE
#644GOGGLE LENS REPLACEMENT STRUCTURE
#645EYE MASK BODY, EYE MASK, AND PREPARATION METHOD THEREOF
#646STRETCH TO FIT BANDAGE
#647USER-CUSTOMIZABLE BANDAGE
#648SHEAR RESISTANT WOUND DRESSING FOR USE IN VACUUM WOUND THERAPY
#649Ankle Support Tape
#650METHODS OF MANUFACTURING ZONED WEBS
#651SANITARY ARTICLE WITH REMOVABLE LATERAL AND/OR END PORTIONS
#652PANT-TYPE ABSORBENT ARTICLE AND MANUFACTURING METHOD THEREOF
#653ELASTIC COVER FOR WEARABLE ARTICLE AND METHOD OF MAKING THEREOF
#654ACTIVE PRESSURE RELIEVING SYSTEM
#655VEHICLE
#656PATIENT SUPPORT SURFACE HAVING A PNEUMATIC CONTROL ASSEMBLY
#657NETWORK-ACCESSIBLE CONTROLLERS RESPONSIBLE FOR MANAGING PRESSURE-MITIGATION DEVICES AND APPROACHES TO INCORPORATING THE SAME INTO EXISTING INFRASTRUCTURE
#658SYSTEMS AND METHODS FOR PATIENT POSITIONING
#659DEVICE FOR CORRECTING POSTURE
#660HEAD SUPPORT AND METHOD FOR USE OF THE HEAD SUPPORT FOR POSITIONING A PATIENT RELATIVE TO A SURGICAL FRAME
#661SURGICAL SUPPORT SYSTEMS, DEVICES, AND METHODS
#662WEARABLE DEVICE AND OPERATING METHOD THEREOF
#663OPTIMIZED KNEE EXOSKELETON WITH TUNABLE COMPLIANCE FOR REHABILITATION AND ASSISTANCE
#664Walking Assistance Apparatus
#665Finger Massage Apparatus
#666AUTONOMOUS POD SYSTEM
#667CONTROL METHOD, DEVICE, TERMINAL, AND STORAGE MEDIUM OF EXTERNAL EAR NEGATIVE PRESSURE GENERATOR
#668METHODS OF STIMULATION USING MULTIPLE VIBRATIONAL ASSEMBLIES
#669APPARATUS AND METHOD FOR REDUCTION OF NEUROLOGICAL MOVEMENT DISORDER SYMPTOMS USING WEARABLE DEVICE
#670CAPACITIVE CELL BASED DEFORMATION SENSING STRUCTURE
#671REAL-TIME METHODS TO ENABLE PRECISION-GUIDED CPR TO IMPROVE NEUROLOGICAL OUTCOME AND PREDICT BRAIN DAMAGE AFTER ISCHEMIC INJURY AND REPERFUSION
#672DETERMINING CHEST COMPRESSION DEPTH USING IMPEDANCE
#673HOT AND COLD THERAPY SYSTEM
#674NEEDLE ASSEMBLIES CONTAINING ORIENTED NEEDLES AND METHODS FOR PRODUCTION THEREOF
#675PILL ORGANIZER
#676Medication packaging
#677Apparatus and System for Remote Medication-Adherence Monitoring
#678Anaerobic Blood Storage Containers
#679HEATING SYSTEM FOR CONTAINERS FOR PHARMACEUTICAL USE
#680HOUSING FOR A FLEXIBLE CONTAINER
#681METHOD FOR THAWING BIOLOGICALLY-DERIVED FROZEN MATERIAL BY VERY HIGH FREQUENCY ELECTROMAGNETIC WAVE IRRADIATION, CRYOPRECIPITATE PRODUCING METHOD, AND THAWING DEVICE
#682PHARMACEUTICAL PRODUCTION FACILITY COMPRISING A MEASURING DEVICE
#683SYSTEM AND METHOD FOR PRECISION ORAL MEDICATION DELIVERY BASED ON REAL-TIME HEALTH MONITORING
#684GASTRIC SECRETION REINFUSION SYSTEM AND METHOD OF OPERATION
#685MEDIUM FOR WATER-FREE ROOT CANAL DISINFECTANT WITH HIGH FLUIDITY, DISINFECTANT USING SAME, AND USE THEREOF
#686WET WIPE
#687DRY CREAMS AND TOPICAL DELIVERY SYSTEMS
#688TEMPERATURE STABLE EMULSIONS
#689SUNSCREEN PREPARATION
#690FRAGRANCE COMPOSITIONS
#691PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS
#692PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT
#693ANTI-AGING PEPTIDE CONTAINING COSMETIC
#694TOPICAL COMPOSITION AND METHOD OF USE
#695BROAD-SPECTRUM PEPTOIDS FOR ORAL AND DENTAL HYGIENE, AND COMPOSITIONS AND METHODS OF USE THEREOF
#696AERATED COSMETIC COMPOSITION
#697DISPERSION COMPRISING A POLYMERIC PARTICLE, A STABILIZER BEARING A C9-C22 ALKYL GROUP, AN OIL AND WATER, AND PROCESS FOR TREATING KERATIN MATERIALS USING THE DISPERSION
#698COSMETIC COMPOSITION FOR SKIN IMPROVEMENT
#699ANTIPERSPIRANT/DEODORANT COMPOSITIONS
#700SIMULATED VERNIX COMPOSITION AND EMULSION INCLUDING THE SAME
#701TRANSDERMAL DELIVERY SYSTEMS FOR ADMINISTRATION OF HYDROPHILIC MOLECULES AND METHODS OF MAKING AND USING SAME
#702EXTENDED-RELEASE FORMULATION CONTAINING CRESOL
#703DRUG DELIVERY FORMULATIONS
#704COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#705DEVICES AND METHODS FOR DELIVERING METHANE INHIBITING COMPOUNDS TO ANIMALS
#706METHOD FOR MANUFACTURING AN INHALABLE POWDER COMPRISING VORICONAZOLE
#707NINTEDANIB AND NINTEDANIB COMBINATION DRY POWDER COMPOSITIONS AND USES
#708METHODS, APPARATUSES AND SYSTEMS FOR INSTILLING STEM CELLS AND PHARMACEUTICALS INTO THE HUMAN VENTRICULAR SYSTEM
#709Aqueous Quetiapine Solutions
#710METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS
#711DELIVERY SYSTEM USING ENGINEERED EXTRACELLULAR VESICLES
#712IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF
#713COMBINED MEDICINAL DRUG INCLUDING LIPOSOME COMPOSITION ENCOMPASSING TOPOTECAN OR SALT THEREOF AND DNA DAMAGE REPAIR INHIBITOR
#714Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides
#715INHALED ANTIBACTERIAL FORMULATIONS FOR TREATING LUNG INFECTIONS
#716SUSTAINED RELEASE INJECTABLE PHARMACEUTICAL FORMULATION OF LEVOTHYROXINE AND PROCESS FOR PREPARATION THEREOF
#717COMPACT COMPOSITIONS COMPRISING ZINGIBERACEAE RHIZOMES FOR ACTIVE AND ADDITIVE APPLICATIONS AND MANUFACTURING METHOD THEREOF
#718Pretomanid Compositions
#719Zwitterionic Hydrogels and Methods of Making and Using Same for Protein Therapy
#720IONIC LIQUID SALTS OF ACTIVE PHARMACEUTICAL INGREDIENTS
#721PHARMACEUTICAL COMPOSITIONS
#722MICROSPHERE FORMULATIONS COMPRISING MULTIPLE NON-IDENTICAL PEPTIDES AND METHODS FOR MAKING THE SAME
#723COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE
#724NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE
#725PROMOTING TRAINED IMMUNITY WITH THERAPEUTIC NANOBIOLOGIC COMPOSITIONS
#726USE OF NANO-CARRIERS FOR DELIVERY OF ACTIVE AGENTS
#727Trans-Epithelial Membrane Drug Delivery System
#728Compositions for reducing oxidative stress
#729METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL
#730ANTICANCER AGENTS BASED ON CYCLOPENTENONES
#731BONE REGENERATION COMPOSITION INCLUDING HORDENINE AND USE THEREOF
#732COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND DISORDERS
#733METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISORDERS
#734COMPOSITIONS COMPRISING ENDOSIDIN 2 FOR REDUCING SARS-COV-2 INFECTION
#735TREATMENT OF LOW-GRADE GLIOMA WITH MIRDAMETINIB
#736NON-LINEAR DOSING OF MIRDAMETINIB
#737SHORT CHAIN FATTY ACID COMPOUNDS AND USES THEREOF
#738MICROBIOTA IMPROVING AGENT
#739METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS
#7402-AMINO-5,5-DIMETHYLHEXANOIC ACID DERIVATIVES AS SORTILIN MODULATORS FOR USE IN THE TREATMENT OF DISEASE OF THE CENTRAL NERVOUS SYSTEM
#741PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS WITH A COMBINATION OF AMINO ACIDS AND ITS USE IN DISEASES CHARACTERIZED BY LIPID ACCUMULATION IN TISSUES
#742Pain Relieving Method
#743METHOD AND DEVICE FOR INFECTION PREVENTION
#744Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
#745OXAFURAMINE, (1R)-N-ETHYL-1-[(2R)-OXOLAN-2-YL]-2-PHENYLETHANAMINE, HYDROCHLORIDE AND DERIVATIVES THEREOF FOR TREATING ALZHEIMER'S DISEASE (AD), VASCULAR DEMENTIA, DEMENTIA WITH LEWY BODIES (DLB), MIXED DEMENTIA, FRONTOTEMPORAL LOBAR DEGENERATION (FTLD), AND PARKINSON'S DISEASE (PD)
#746COMPOSITION FOR USE IN THE CUTANEOUS SYNTHESIS OF HYALURONIC ACID, IN AN IMMUNO-CUTANEOUS RESPONSE AND TO IMPROVE SKIN
#747N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS
#748POTASSIUM-COMPETITIVE ACID BLOCKERS FOR THE TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS
#749DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA
#750PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF EDARAVONE AND METHOD OF ADMINISTERING SAME
#751STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
#752Nasal Compositions and Method of Use Thereof
#753OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO
#754AGENT FOR REDUCING VISCERAL FAT WEIGHT
#755METHODS OF USING A (THIAZOLYL)BENZENESULFONAMIDE DERIVATIVE
#756SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION
#757NEW CRYSTAL FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#758ESTROGEN-RELATED RECEPTOR ALPHA MODULATORS
#759COMBINATION OF DUAL ATM AND DNA-PK INHIBITORS AND IMMUNOTHERAPEUTIC AGENTS FOR USE IN CANCER THERAPY
#760MALEATE OF NICOTINYL ALCOHOL ETHER DERIVATIVE, CRYSTAL FORM THEREOF, AND APPLICATION THEREOF
#761STABILIZED PHARMACEUTICAL COMPOSITION OF 1,4-DIHYDROPYRIDINES WITH HYDROGEN ATOM TRANSFER (HAT) ANTIOXIDANTS
#762TREATMENT OF HIDRADENITIS SUPPURATIVA WITH ORISMILAST
#7632H-INDAZOLE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE
#764FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
#765METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE
#7663-(Hydroxy)-Pyridin-4(1H)-One Compounds and Methods of Making and Using the Same
#767STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN
#768NEUROPATHIC AND CHRONIC PAIN FORMULATIONS
#769THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS
#770Deuterated Domperidone for Treating Gastroparesis
#771ORAL COMPOSITION COMPRISING NICOTINAMIDE
#772NEW FORMULATION OF ATROPINE
#773THERAPEUTIC USES OF BRADYKININ B2-RECEPTOR ANTAGONISTS
#774BRONCHODILATORS FOR TREATING OBSTRUCTIVE LUNG DISEASE
#775COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
#776COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
#777BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS
#778TREATMENT OF CANCER USING ARIPIPRAZOLE AND ANTICANCER AGENT
#779PHARMACEUTICAL COMPOSITIONS
#780MACROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER
#781Crystalline Forms of a BTK Inhibitor
#782LIQUID COMPOSITIONS
#783USE OF HETEROCYCLIC COMPOUND IN TREATING DISEASES RELATED TO KINASE DRUG-RESISTANT MUTATION AND METHOD THEREFOR
#784METHODS OF TREATING SYNOVIAL SARCOMA PATHOGENESIS BY SUMO2 INHIBITION
#785ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN WITH BREAST CANCER
#786COMBINATION THERAPY USING A SUBSTITUTED PYRIMIDIN-4(3H)-ONE AND NIVOLUMAB AS WELL AS ITS USE IN THE TREATMENT OF CANCER
#787CRYSTAL FORM OF AZETIDINE-SUBSTITUTED COMPOUND
#788THERAPEUTIC METHODS
#789RXFP1 AGONISTS
#790THERAPEUTICS AGAINST PATHOGENIC CORONAVIRUSES
#791SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
#792MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF
#793MACROCYCLIC DERIVATIVE AND USE THEREOF
#794PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
#795Combination Therapy
#796NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
#797Methods of Using RHO Kinase Inhibitors to Treat Alzheimer's Disease
#798USE OF GABAA RECEPTOR MODULATORS FOR TREATMENT OF ITCH
#799PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#800FLUTICASONE DELIVERY COMPOSITIONS, DEVICES AND METHODS
#801METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION
#802METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS
#803PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTION AND/OR TREATMENT OF INFLAMMATION
#804METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS
#805COMPOUNDS FOR THE TREATMENT OF CANCER
#806USE OF ANDROGEN RECEPTOR-MEDIATED MECHANISMS IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#807OPTHALMIC FORMULATIONS AND USES THEREOF
#808PHARMACEUTICAL COMPOSITION COMPRISING ACETYLSALICYLIC ACID AND PROTON PUMP INHIBITOR
#809APPLICATION OF TETRACYCLINE COMPOUND IN TREATMENT OF TUMOR
#810PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION
#811METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASE USING A SUBSTITUTED ADENINYL-PROPYLOXY PHOSPHONIC ACID OR RELATED COMPOUND
#812METHOD AND COMPOSITION FOR TREATING, ALLEVIATING OR PREVENTING A DISEASE OR CONDITION CAUSED BY AIR POLLUTANT
#813SYNBIOTIC TREATMENT REGIMENS
#814USE OF BACTERIORUBERINS AND GLYCOSYL DERIVATIVES THEREOF TO PREVENT AND TREAT DISEASES INVOLVING DYSREGULATED PROTEIN AGGREGATION, SUCH AS NEURODEGENERATIVE DISEASES
#815TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#816COMPOSITIONS AND METHODS FOR RESTORING OR INCREASING TISSUE PERFUSION
#817TRANSCRIPTIONAL INHIBITOR FOR IMMUNE-RELATED GENE
#818Oxygen-containing preparation for treating acne and wounds, a preparation method and an application device thereof
#819COMPOSITION AND METHOD FOR TREATING HEARING LOSS
#820Compositions and Methods for the Treatment of Bacterial Vaginosis
#821Tumor Treatment
#822ANIMAL FOOD COMPOSITIONS CONTAINING A COMBINATION OF SPRAY-DRIED PLASMA AND FRUCTO-OLIGOSACCHARIDES
#823ENGINEERED IMMUNE CELLS TO TARGET SARS-COV2
#824SMALL MOLECULE-REGULATED CELL SIGNALING EXPRESSION SYSTEM
#825Chimeric Antigen Receptor Molecule for Specifically Recognizing Baff-R and Application of Chimeric Antigen Receptor Molecule
#826CHIMERIC ANTIGEN RECEPTOR COMPOSITIONS AND USES
#827BCMA/CD19 CAR FOR TREATING MULTIPLE MYELOMA
#828ISOLATED IMMUNE CELL EXPRESSING A RECEPTOR, INTERLEUKIN-7, AND CHEMOKINE (C-C MOTIF) LIGAND 19
#829STEM CELL-DERIVED EXTRACELLULAR VESICLES AND METHODS OF USE THEREOF
#830STROMAL STEM CELL THERAPEUTICS AND METHODS OF USE
#831COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS
#832USE OF EXTRACT FROM RABBIT SKIN INFLAMED BY VACCINIA VIRUS IN TREATMENT OF ALZHEIMER'S DISEASE
#833GENERATION OF ALVEOLAR EPITHELIAL TYPE 1 (AT1) CELLS
#834COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID)
#835IMMUNE CELL INHIBITION BY IMMUNE CHECKPOINT ENGAGERS
#836PRENATAL SUPPLEMENT
#837THERAPEUTIC AND PROPHYLACTIC USE OF MICROORGANISMS
#838COMPOSITION FOR PREVENTING OR TREATING DETERIORATION IN BRAIN FUNCTION OR MAINTAINING OR IMPROVING BRAIN FUNCTION
#839COMPOSITIONS AND METHODS FOR TREATING DISEASE II
#840Treatment and/or Prevention of Digestive Disorder by a Bacterial Composition of Propionibacterium Freudenreichii and Bifidobacterium Longum
#841MICROBIAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
#842COMPOSITIONS CONTAINING INDOLE-DERIVED METABOLITES AND METHODS OF USE THEREOF
#843Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
#844COMMENSAL BACTERIA PROMOTE ENDOCRINE-RESISTANCE IN PROSTATE CANCER VIA ANDROGEN BIOSYNTHESIS
#845COMPOSITIONS CONTAINING INDOLE-DERIVED METABOLITES AND METHODS OF USE THEREOF
#846COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN
#847MODIFIED MICROORGANISMS EXPRESSING SagA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPY
#848COMPOSITION FOR INFLAMMATORY BOWEL DISEASE
#849SYNTHETIC VIRUSES
#850PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA
#851CHAGA MUSHROOM-RELATED FORMULATIONS, CHEMICAL COMPOUNDS, AND METHODS OF PRODUCTION AND USE THEREOF
#852METHOD AND COMPOSITION FOR ENHANCING IMMUNE SYSTEM
#853NUTRACEUTICAL COMPOUNDS USEFUL IN THE TREATMENT OF CORONAVIRUS DISEASE
#854Vaporized Medicants and Methods of Use
#855OPHTHALMIC COMPOSITION
#856PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS
#857SAFFRON AS ANTI-INFLAMMATORY AGENT IN TREATING INFLAMMATORY BOWEL DISEASE
#8585a-REDUCTASE INHIBITOR
#859GINGER EXTRACT POLYSACCHARIDE COMPOSITION AND METHOD OF SUPPORTING THE IMMUNE SYSTEM
#860COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
#861PEPTOIDS FOR TREATING FILOVIRIDAE INFECTIONS
#862BROAD-SPECTRUM PEPTOIDS FOR TREATMENT OR PREVENTION OF WOUND INFECTIONS, AND COMPOSITIONS AND METHODS OF USE THEREOF
#863COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)
#864TOPICAL CREAM AND METHOD OF USE
#865COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS
#866AN ANTICANCER THERAPY TARGETING RAS AND OTHER ONCOGENIC SIGNALS BY INHIBITION OF DYNAMIC BLEBBING AND/OR SEPTINS
#867METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS
#868COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES
#869Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders
#870INTERFERON-BASED CANCER TREATMENT METHOD, AND PHARMACEUTICAL COMBINATION
#871BCL2 INHIBITOR AND PEPTIDE COMBINATION THERAPY FOR TREATING PROLIFERATIVE DISEASES
#872GLP-1 PRODRUGS AND USES THEREOF
#873FORMULATIONS
#874PTH Prodrugs
#875TREATMENT AND PREVENTION OF OSTEOPOROSIS IN HIGH BODY MASS INDEX INDIVIDUALS
#876METHODS OF INDUCING IMMUNE TOLERANCE TO CLOTTING FACTORS
#877FOOD COMPOSITION FOR SUPPRESSING MUSCLE FATIGUE AND/OR SUDDEN MUSCLE PAIN
#878METHODS FOR TREATING DILATED CARDIOMYOPATHY AND PHARMACEUTICAL COMPOSITIONS THEREFOR
#879ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS
#880Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof
#881COMPOSITIONS FOR BREAKDOWN OF GLUTEN PROTEINS
#882METHODS OF AND COMPOSITIONS FOR TREATMENT OF UPPER LIMB SPASTICITY
#883A Subunit Cryptococcus Vaccine
#884METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS
#885Treatment and Prophylaxis of Amyloidosis
#886ANTI-TUMOUR RESPONSES TO CYTOKERATINS
#887METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING ANUCLEATE CELLS
#888CTA VACCINE CASSETTES
#889NANO-ENHANCED VACCINE
#890ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF
#891METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT
#892METHODS FOR PREDICTING EFFICACY OF A MODIFIED LIVE PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINE
#893NUCLEIC ACID MOLECULES AND USES THEREOF
#894VACCINATION OF IMMUNOCOMPROMISED SUBJECTS
#895VACCINE COMPOSITION FOR NOVEL CORONAVIRUS INFECTION
#896NOVEL NUCLEIC ACID MOLECULE
#897TREATMENT OF CANCER USING MRNA-MEDIATED VIRUS VACCINATION ANTIGENS DELIVERED BY ATTENUATED BACTERIA
#898VIRUS ENCODING TRANSGENES TO COMPLEMENT CELLULAR THERAPY
#899IMMUNOGENIC COMPOSITIONS FOR TREATMENT OF HEPATITIS B
#900POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS